Inventor
SMAGGHE BENOIT
US13 patents
Patents
13 patentsUS11746159B2Sep 5, 2023
Humanized anti-MUC1* antibodies
MINERVA BIOTECHNOLOGIES CORP8 citations84
US11591565B2Feb 28, 2023
Media for stem cell proliferation and induction
MINERVA BIOTECHNOLOGIES CORP5 citations84
US12115192B2Oct 15, 2024
Chimeric antigen receptor compositions and methods for treating MUC1* diseases
MINERVA BIOTECHNOLOGIES CORP3 citations73
US12049514B2Jul 30, 2024
Anti-NME antibody and method of treating cancer or cancer metastasis
MINERVA BIOTECHNOLOGIES CORP3 citations73
US12037413B2Jul 16, 2024
Anti-NME antibody and method of treating cancer or cancer metastasis
MINERVA BIOTECHNOLOGIES CORP3 citations73
US12006371B2Jun 11, 2024
Humanized anti-MUC1* antibodies
MINERVA BIOTECHNOLOGIES CORP3 citations73
US11976295B2May 7, 2024
Media for stem cell proliferation and induction
MINERVA BIOTECHNOLOGIES CORP4 citations73
US11897967B2Feb 13, 2024
Humanized anti-MUC1* antibodies
MINERVA BIOTECHNOLOGIES CORP3 citations73
US11702483B2Jul 18, 2023
Method of treating an NME7 expressing cancer with a peptide
MINERVA BIOTECHNOLOGIES CORP2 citations72
US12583927B2Mar 24, 2026
Anti-variable MUC1* antibodies and uses thereof
MINERVA BIOTECHNOLOGIES CORP0 citations61
US12479928B2Nov 25, 2025
Anti-cancer peptide
MINERVA BIOTECHNOLOGIES CORP0 citations61
US12415868B1Sep 16, 2025
Anti-NME antibody and method of treating cancer or cancer metastasis
MINERVA BIOTECHNOLOGIES CORP0 citations51
US12491259B2Dec 9, 2025
Anti-variable MUC1* antibodies and uses thereof
MINERVA BIOTECHNOLOGIES CORP0 citations46